vs

Side-by-side financial comparison of CABOT CORP (CBT) and MATTEL INC (MAT). Click either name above to swap in a different company.

MATTEL INC is the larger business by last-quarter revenue ($862.2M vs $849.0M, roughly 1.0× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs 7.1%, a 1.5% gap on every dollar of revenue. On growth, MATTEL INC posted the faster year-over-year revenue change (4.3% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $-88.1M). Over the past eight quarters, CABOT CORP's revenue compounded faster (-8.7% CAGR vs -10.6%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Mattel Films was the film production division of American toy and entertainment company Mattel that operated from September 6, 2018 to June 2, 2025. It succeeded Mattel Playground Productions, which was formed on October 16, 2013 as part of Mattel Global Brands, a unified media structural and strategy unit, as itself the successor to Mattel Entertainment and Mattel Studios, Mattel's prior entertainment brands/banners.

CBT vs MAT — Head-to-Head

Bigger by revenue
MAT
MAT
1.0× larger
MAT
$862.2M
$849.0M
CBT
Growing faster (revenue YoY)
MAT
MAT
+15.4% gap
MAT
4.3%
-11.1%
CBT
Higher net margin
CBT
CBT
1.5% more per $
CBT
8.6%
7.1%
MAT
More free cash flow
CBT
CBT
$145.1M more FCF
CBT
$57.0M
$-88.1M
MAT
Faster 2-yr revenue CAGR
CBT
CBT
Annualised
CBT
-8.7%
-10.6%
MAT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
MAT
MAT
Revenue
$849.0M
$862.2M
Net Profit
$73.0M
$61.0M
Gross Margin
24.9%
44.9%
Operating Margin
15.2%
Net Margin
8.6%
7.1%
Revenue YoY
-11.1%
4.3%
Net Profit YoY
-21.5%
251.4%
EPS (diluted)
$1.37
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
MAT
MAT
Q1 26
$862.2M
Q4 25
$849.0M
$1.8B
Q3 25
$899.0M
$1.7B
Q2 25
$923.0M
$1.0B
Q1 25
$936.0M
$826.6M
Q4 24
$955.0M
$1.6B
Q3 24
$1.0B
$1.8B
Q2 24
$1.0B
$1.1B
Net Profit
CBT
CBT
MAT
MAT
Q1 26
$61.0M
Q4 25
$73.0M
$106.2M
Q3 25
$43.0M
$278.4M
Q2 25
$101.0M
$53.4M
Q1 25
$94.0M
$-40.3M
Q4 24
$93.0M
$140.9M
Q3 24
$137.0M
$372.4M
Q2 24
$109.0M
$56.9M
Gross Margin
CBT
CBT
MAT
MAT
Q1 26
44.9%
Q4 25
24.9%
45.9%
Q3 25
24.5%
50.0%
Q2 25
26.4%
50.9%
Q1 25
25.7%
49.4%
Q4 24
24.6%
50.7%
Q3 24
24.0%
53.1%
Q2 24
25.2%
49.2%
Operating Margin
CBT
CBT
MAT
MAT
Q1 26
Q4 25
15.2%
8.0%
Q3 25
15.2%
21.9%
Q2 25
18.1%
7.7%
Q1 25
17.3%
-6.4%
Q4 24
16.2%
9.6%
Q3 24
15.0%
26.5%
Q2 24
16.9%
7.7%
Net Margin
CBT
CBT
MAT
MAT
Q1 26
7.1%
Q4 25
8.6%
6.0%
Q3 25
4.8%
16.0%
Q2 25
10.9%
5.2%
Q1 25
10.0%
-4.9%
Q4 24
9.7%
8.6%
Q3 24
13.7%
20.2%
Q2 24
10.7%
5.3%
EPS (diluted)
CBT
CBT
MAT
MAT
Q1 26
$0.20
Q4 25
$1.37
$0.32
Q3 25
$0.80
$0.88
Q2 25
$1.86
$0.16
Q1 25
$1.69
$-0.12
Q4 24
$1.67
$0.40
Q3 24
$2.41
$1.09
Q2 24
$1.94
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
MAT
MAT
Cash + ST InvestmentsLiquidity on hand
$230.0M
$866.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$1.6B
$2.1B
Total Assets
$3.8B
$6.3B
Debt / EquityLower = less leverage
1.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
MAT
MAT
Q1 26
$866.0M
Q4 25
$230.0M
$1.2B
Q3 25
$258.0M
$691.9M
Q2 25
$239.0M
$870.5M
Q1 25
$213.0M
$1.2B
Q4 24
$183.0M
$1.4B
Q3 24
$223.0M
$723.5M
Q2 24
$197.0M
$722.4M
Total Debt
CBT
CBT
MAT
MAT
Q1 26
$2.3B
Q4 25
$2.3B
Q3 25
$1.1B
$2.3B
Q2 25
$2.3B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$1.1B
$2.3B
Q2 24
$2.3B
Stockholders' Equity
CBT
CBT
MAT
MAT
Q1 26
$2.1B
Q4 25
$1.6B
$2.2B
Q3 25
$1.6B
$2.3B
Q2 25
$1.5B
$2.2B
Q1 25
$1.4B
$2.1B
Q4 24
$1.4B
$2.3B
Q3 24
$1.4B
$2.3B
Q2 24
$1.3B
$2.0B
Total Assets
CBT
CBT
MAT
MAT
Q1 26
$6.3B
Q4 25
$3.8B
$6.6B
Q3 25
$3.8B
$6.6B
Q2 25
$3.8B
$6.2B
Q1 25
$3.8B
$6.2B
Q4 24
$3.6B
$6.5B
Q3 24
$3.7B
$6.5B
Q2 24
$3.6B
$5.9B
Debt / Equity
CBT
CBT
MAT
MAT
Q1 26
1.11×
Q4 25
1.04×
Q3 25
0.70×
1.03×
Q2 25
1.08×
Q1 25
1.10×
Q4 24
1.03×
Q3 24
0.75×
1.01×
Q2 24
1.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
MAT
MAT
Operating Cash FlowLast quarter
$126.0M
Free Cash FlowOCF − Capex
$57.0M
$-88.1M
FCF MarginFCF / Revenue
6.7%
-10.2%
Capex IntensityCapex / Revenue
8.1%
7.6%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
MAT
MAT
Q1 26
Q4 25
$126.0M
$796.6M
Q3 25
$219.0M
$72.0M
Q2 25
$249.0M
$-300.1M
Q1 25
$73.0M
$24.8M
Q4 24
$124.0M
$862.1M
Q3 24
$204.0M
$155.8M
Q2 24
$207.0M
$-252.9M
Free Cash Flow
CBT
CBT
MAT
MAT
Q1 26
$-88.1M
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
Q1 25
$1.0M
Q4 24
$47.0M
Q3 24
$112.0M
Q2 24
$155.0M
FCF Margin
CBT
CBT
MAT
MAT
Q1 26
-10.2%
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
Q1 25
0.1%
Q4 24
4.9%
Q3 24
11.2%
Q2 24
15.3%
Capex Intensity
CBT
CBT
MAT
MAT
Q1 26
7.6%
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
Q1 25
7.7%
Q4 24
8.1%
Q3 24
9.2%
Q2 24
5.1%
Cash Conversion
CBT
CBT
MAT
MAT
Q1 26
Q4 25
1.73×
7.50×
Q3 25
5.09×
0.26×
Q2 25
2.47×
-5.62×
Q1 25
0.78×
Q4 24
1.33×
6.12×
Q3 24
1.49×
0.42×
Q2 24
1.90×
-4.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

MAT
MAT

Segment breakdown not available.

Related Comparisons